Nolato AB (publ) (NLTBF)
OTCMKTS · Delayed Price · Currency is USD
6.53
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Nolato AB Market Cap
Nolato AB has a market cap or net worth of $1.56 billion as of February 12, 2026. Its market cap has increased by 13.31% in one year.
Market Cap
1.56B
Enterprise Value
1.69B
Revenue
1.02B
Ranking
n/a
PE Ratio
18.63
Stock Price
$6.53
Market Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 96.98M to 1.56B, an increase of 1,508.22%. That is a compound annual growth rate of 9.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.56B | -13.89% |
| Dec 30, 2025 | 1.81B | 37.02% |
| Dec 30, 2024 | 1.32B | -6.44% |
| Dec 29, 2023 | 1.41B | 0.05% |
| Dec 30, 2022 | 1.41B | -56.05% |
| Dec 30, 2021 | 3.21B | 18.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 337.95M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 59.50M |
| Positron | 58.27M |
| Vivos | 31.43M |
| Guided Therapeutics | 28.51M |